Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 2
1966 8
1967 2
1972 1
1973 2
1974 1
1976 1
1977 1
1978 7
1979 4
1980 6
1981 4
1982 5
1983 4
1984 9
1985 9
1986 12
1987 9
1988 10
1989 11
1990 6
1991 11
1992 32
1993 29
1994 39
1995 27
1996 34
1997 53
1998 48
1999 45
2000 40
2001 58
2002 66
2003 99
2004 117
2005 113
2006 134
2007 179
2008 171
2009 222
2010 285
2011 383
2012 432
2013 507
2014 528
2015 627
2016 604
2017 733
2018 747
2019 792
2020 912
2021 1076
2022 1339
2023 1363
2024 1246
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

11,878 results

Results by year

Filters applied: . Clear all
Page 1
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma.
Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F, Wang Y, Wei J, Chen H, Tartarone A, Velotta JB, Dayyani F, Gabriel E, Wakefield CJ, Kidane B, Carbonelli C, Long L, Liu Z, Su J, Li Z. Liu Z, et al. Among authors: su j. Cancer Cell. 2023 Nov 13;41(11):1852-1870.e9. doi: 10.1016/j.ccell.2023.09.011. Epub 2023 Oct 12. Cancer Cell. 2023. PMID: 37832554 Free article.
Signaling pathways and targeted therapies for psoriasis.
Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Guo J, et al. Among authors: su j. Signal Transduct Target Ther. 2023 Nov 27;8(1):437. doi: 10.1038/s41392-023-01655-6. Signal Transduct Target Ther. 2023. PMID: 38008779 Free PMC article. Review.
Augmentation of scleral glycolysis promotes myopia through histone lactylation.
Lin X, Lei Y, Pan M, Hu C, Xie B, Wu W, Su J, Li Y, Tan Y, Wei X, Xue Z, Xu R, Di M, Deng H, Liu S, Yang X, Qu J, Chen W, Zhou X, Zhao F. Lin X, et al. Among authors: su j. Cell Metab. 2024 Mar 5;36(3):511-525.e7. doi: 10.1016/j.cmet.2023.12.023. Epub 2024 Jan 16. Cell Metab. 2024. PMID: 38232735
AI-enabled organoids: Construction, analysis, and application.
Bai L, Wu Y, Li G, Zhang W, Zhang H, Su J. Bai L, et al. Among authors: su j. Bioact Mater. 2023 Sep 16;31:525-548. doi: 10.1016/j.bioactmat.2023.09.005. eCollection 2024 Jan. Bioact Mater. 2023. PMID: 37746662 Free PMC article. Review.
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.
Zhou C, Qin Y, Zhao W, Liang Z, Li M, Liu D, Bai L, Chen Y, Chen Y, Cheng Y, Chu T, Chu Q, Deng H, Dong Y, Fang W, Fu X, Gao B, Han Y, He Y, Hong Q, Hu J, Hu Y, Jiang L, Jin Y, Lan F, Li Q, Li S, Li W, Li Y, Liang W, Lin G, Lin X, Liu M, Liu X, Liu X, Liu Z, Lv T, Mu C, Ouyang M, Qin J, Ren S, Shi H, Shi M, Su C, Su J, Sun D, Sun Y, Tang H, Wang H, Wang K, Wang K, Wang M, Wang Q, Wang W, Wang X, Wang Y, Wang Z, Wang Z, Wu L, Wu D, Xie B, Xie M, Xie X, Xie Z, Xu S, Xu X, Yang X, Yin Y, Yu Z, Zhang J, Zhang J, Zhang J, Zhang X, Zhang Y, Zhong D, Zhou Q, Zhou X, Zhou Y, Zhu B, Zhu Z, Zou C, Zhong N, He J, Bai C, Hu C, Li W, Song Y, Zhou J, Han B, Varga J, Barreiro E, Park HY, Petrella F, Saito Y, Goto T, Igai H, Bravaccini S, Zanoni M, Solli P, Watanabe S, Fiorelli A, Nakada T, Ichiki Y, Berardi R, Tsoukalas N, Girard N, Rossi A, Passaro A, Hida T, Li S, Chen L, Chen R. Zhou C, et al. Among authors: su j. Transl Lung Cancer Res. 2023 Aug 30;12(8):1661-1701. doi: 10.21037/tlcr-23-339. Epub 2023 Aug 24. Transl Lung Cancer Res. 2023. PMID: 37691866 Free PMC article. Review.
11,878 results
You have reached the last available page of results. Please see the User Guide for more information.